Literature DB >> 12767218

Structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3 A resolution: evidence for multiple substrate binding modes.

Michael R Wester1, Eric F Johnson, Cristina Marques-Soares, Patrick M Dansette, Daniel Mansuy, C David Stout.   

Abstract

The structure of rabbit microsomal cytochrome P450 2C5/3LVdH complexed with a substrate, 4-methyl-N-methyl-N-(2-phenyl-2H-pyrazol-3-yl)benzenesulfonamide (DMZ), was determined by X-ray crystallography to 2.3 A resolution. Substrate docking studies and electron density maps indicate that DMZ binds to the enzyme in two antiparallel orientations of the long axis of the substrate. One orientation places the principal site of hydroxylation, the 4-methyl group, 4.4 A from the heme Fe, whereas the alternate conformation positions the second, infrequent site of hydroxylation at >5.9 A from the heme Fe. Comparison of this structure to that obtained previously for the enzyme indicates that the protein closes around the substrate and prevents open access of water from bulk solvent to the heme Fe. This reflects a approximately 1.5 A movement of the F and G helices relative to helix I. The present structure provides a complete model for the protein from residues 27-488 and defines two new helices F' and G'. The G' helix is likely to contribute to interactions of the enzyme with membranes. The relatively large active site, as compared to the volume occupied by the substrate, and the flexibility of the enzyme are likely to underlie the capacity of drug-metabolizing enzymes to metabolize structurally diverse substrates of different sizes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767218     DOI: 10.1021/bi0273922

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  39 in total

Review 1.  Conformational plasticity and structure/function relationships in cytochromes P450.

Authors:  Thomas C Pochapsky; Sophia Kazanis; Marina Dang
Journal:  Antioxid Redox Signal       Date:  2010-10       Impact factor: 8.401

2.  Crystal structure of human cytochrome P450 2D6 with prinomastat bound.

Authors:  An Wang; Uzen Savas; Mei-Hui Hsu; C David Stout; Eric F Johnson
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

3.  Do mammalian cytochrome P450s show multiple ligand access pathways and ligand channelling?

Authors:  Karin Schleinkofer; Peter J Winn; Susanne K Lüdemann; Rebecca C Wade
Journal:  EMBO Rep       Date:  2005-06       Impact factor: 8.807

4.  A support vector machine approach to classify human cytochrome P450 3A4 inhibitors.

Authors:  Jan M Kriegl; Thomas Arnhold; Bernd Beck; Thomas Fox
Journal:  J Comput Aided Mol Des       Date:  2005-03       Impact factor: 3.686

5.  Conformational equilibrium of cytochrome P450 BM-3 complexed with N-palmitoylglycine: a replica exchange molecular dynamics study.

Authors:  Krishna Pratap Ravindranathan; Emilio Gallicchio; Richard A Friesner; Ann E McDermott; Ronald M Levy
Journal:  J Am Chem Soc       Date:  2006-05-03       Impact factor: 15.419

6.  Hybrid homology modeling and mutational analysis of cytochrome P450C24A1 (CYP24A1) of the Vitamin D pathway: insights into substrate specificity and membrane bound structure-function.

Authors:  Andrew J Annalora; Ekaterina Bobrovnikov-Marjon; Rita Serda; Andrzej Pastuszyn; Sandra E Graham; Craig B Marcus; John L Omdahl
Journal:  Arch Biochem Biophys       Date:  2006-12-03       Impact factor: 4.013

Review 7.  Substrate binding to cytochromes P450.

Authors:  Emre M Isin; F Peter Guengerich
Journal:  Anal Bioanal Chem       Date:  2008-07-13       Impact factor: 4.142

8.  Structural characterization of human cytochrome P450 2C19: active site differences between P450s 2C8, 2C9, and 2C19.

Authors:  R Leila Reynald; Stefaan Sansen; C David Stout; Eric F Johnson
Journal:  J Biol Chem       Date:  2012-11-01       Impact factor: 5.157

Review 9.  Structural diversity of eukaryotic membrane cytochrome p450s.

Authors:  Eric F Johnson; C David Stout
Journal:  J Biol Chem       Date:  2013-04-30       Impact factor: 5.157

10.  Characterization of CYP2A13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers.

Authors:  Jaime D'Agostino; Xiuling Zhang; Hong Wu; Guoyu Ling; Suping Wang; Qing-Yu Zhang; Fucai Liu; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2008-07-31       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.